+ 2.58
+ 0.78%
+ 2.29
+ 0.66%
+ 2.93
+ 0.7%
+ 1.55
+ 0.91%

Apple, Biogen And More 'Fast Money' Picks For October 1

October 1, 2019 11:05 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

On CNBC's "Fast Money Final Trade," Pete Najarian said Bristol-Myers Squibb Co (NYSE:BMY) is going higher. He saw a bullish options activity in the name.

Tim Seymour said he is a buyer of Twitter Inc (NYSE:TWTR). He thinks the valuation makes sense.

See Also: Najarian Brothers See Unusual Options Activity In Bristol-Myers, AMD And More

Steve Grasso wants to buy Apple Inc. (NASDAQ:AAPL). He believes it's going to break out on the upside.

Guy Adami would buy Biogen Inc (NASDAQ:BIIB). He thinks it's too cheap.

Related Articles

Jim Lebenthal Isn't Worried About Apple's Stock

Apple Inc (NASDAQ: AAPL) is a multi-year hold, Cerity Partners' Jim Lebenthal said Wednesday on CNBC's "Fast Money: Halftime Report." Cash flow is strong and share buybacks will continue into 2022 and 2023, Lebenthal said.  read more

Jim Cramer: 'FAANG Owns The Future'

Jim Cramer isn't giving up on FAANG stocks, he said Wednesday night on CNBC's "Mad Money." read more

Looking For Ideas Beyond Apple? Expert Traders Say These 2 Stocks Could Benefit From Halo Effect

Investors looking beyond Apple Inc. (NASDAQ: AAPL) could capitalize on two alternative stocks that may benefit from the tech giant’s halo effect following the announcement of its read more

Guy Adami Thinks Bitcoin Could Double In One Year's Time

Those who think that Bitcoin (CRYPTO:BTC) is going to double during the next year are probably going to be right, Fast Money trader Guy Adami said Friday on CNBC's "Power Lunch." read more